Thong Nhat Hospital in Ho Chi Minh City is a final hospital in the department of geriatrics, receiving hundreds of patients for examination every day, most of whom have chronic diseases of the elderly, especially the disease of concern, heart failure.
Heart failure is the outcome of most cardiovascular diseases, with an increasing incidence due to an increase in cardiovascular diseases and average life expectancy. The consequences of heart failure are very heavy, increase mortality, re -hospitalization and seriously decrease in the quality of life, creating a great burden for the health and society.
Patient H.V.T (68 years old, Hoc Mon district, Ho Chi Minh City) was unfortunately diagnosed with heart failure for 3 years. Over the years, Mr. T. has always tried to treat and re-examine regularly to limit complications of heart failure that can suddenly break out.
Mr. T. was continued to be prescribed medicine and monitored at home by the doctor. For patients like Mr. T., it is always necessary to have relatives by their side so that when there are signs of illness, they can be promptly taken to the emergency room.
According to Associate Professor, Dr. Nguyen Van Tan - Head of the Department of Emergency & Intervention Cardiology, Thong Nhat Hospital, the focus of modern treatment strategy is the "four pillars" model. This is a combination of four groups of platform drugs, in which the inhibitory group SGLT2 is considered a remarkable improvement, helping to significantly reduce the risk of hospitalization and death in all patients with heart failure.
However, the key to success lies not only in using the right medicine, but also in actively and drastically optimizing dosage. Associate Professor. Tan said that instead of waiting, new regimens encourage quick optimization of drug doses immediately after patients with heart failure are discharged from the hospital. "This approach can be likened to 'chemotherapy in cancer', requiring determination and close monitoring for the first 6 weeks to achieve maximum effectiveness, helping to significantly reduce the rate of hospitalization and mortality," said Associate Professor. Tan explained.
To safely implement this drastic strategy, the personalization factor plays a leading role. Instead of increasing the dose of Forms, doctors must closely monitor each patient's indicators such as blood pressure, heart rate, kidney function and blood potassium levels before each adjustment. "We adjust the dosage based on the tolerance and response of that patient in real time," Associate Professor. Tan emphasized.
From accurate disease classification, using biological imprints for orientation, to flexible pattern adjustment, personalized medicine is opening up a brighter future, helping to prolong life and improve the quality of life for millions of patients with heart failure.
